Tyler T. Cooper

Tyler T. Cooper

Auto-generated profile, based on publicly available information

Tyler T. Cooper

Department of Biochemistry, The University of Western Ontario, London ON, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2021 in The Analyst
Verified
Journal Article
Closed access
PDF file
NĆNina M. Ćulum
Nina M. Ćulum
TCTyler T. Cooper
Tyler T. Cooper
GLGilles A. Lajoie
Gilles A. Lajoie
TDThamara Dayarathna
Thamara Dayarathna
SPStephen H. Pasternak
Stephen H. Pasternak
FLFrancois Lagugne-Labarthet
Francois Lagugne-Labarthet
EVs derived from normal ovarian (hIOSE) and ovarian cancer (OVCAR3, OV-90, EOC6, EOC18) cells were analysed by SERS. The SERS spectra of normal and cancer EVs were differentiated by PCA and machine learning, through which we achieved >99% accuracy.

1 July 2021 in Biomaterials
Verified
Journal Article
Closed access
CLChristopher J. Leclerc
Christopher J. Leclerc
TCTyler T. Cooper
Tyler T. Cooper
GBGillian I. Bell
Gillian I. Bell
GLGilles A. Lajoie
Gilles A. Lajoie
LFLauren E. Flynn
Lauren E. Flynn
DHDavid Hess
David Hess

17 March 2025 in Nanoscale
Verified
Journal Article
Open access
PDF file
LVLorena Veliz
Lorena Veliz
CLCédric Lambin
Cédric Lambin
TCTyler T. Cooper
Tyler T. Cooper
WMW. Michael McCarvell
W. Michael McCarvell
GLGilles A. Lajoie
Gilles A. Lajoie
FLFrancois Lagugne-Labarthet
Francois Lagugne-Labarthet
2D-MoS 2 flakes as SERS and TERS platforms for the characterization of extracellular vesicles derived from blood plasma for ovarian cancer detection (Developed using CorelDRAW).

6 February 2025 in Acta Biomaterialia
Verified
Journal Article
Open access
JWJohn T. Walker
John T. Walker
TCTyler T. Cooper
Tyler T. Cooper
JDJoy Dunmore-Buyze
Joy Dunmore-Buyze
FSFiona E. Serack
Fiona E. Serack
CBCourtney Brooks
Courtney Brooks
LFLauren E. Flynn
Lauren E. Flynn
The delivery of adipose-derived stromal cells (ASCs) on cell-instructive decellularized adipose tissue (DAT) scaffolds is a promising strategy for stimulating host-derived soft tissue regeneration. However, a better understanding of the mechanisms through which ASCs modulate regeneration in vivo is needed to harness these cells more effectively. In this study, DAT scaffolds, both with and without seeded syngeneic DsRED+ mouse ASCs, were implanted into immunocompetent C57BL/6 mice. Downstream analyses focused on assessing donor ASC persistence and phenotype, as well as the effects of ASC seeding on host macrophage polarization and the perfused host vascular network. Notably, most donor ASCs were cleared from the scaffolds by 2 weeks. Mass spectrometry-based proteomics indicated that the transplanted ASCs maintained their pre-implantation phenotype up to 1 week in vivo, suggesting that the cells were not undergoing programmed cell death. A higher fraction of the infiltrating host macrophages expressed CD68 and Arginase-1 in the ASC-seeded implants up to 1-week post-implantation. Interestingly, a small population of phagocytic macrophages, identified by uptake of DsRED protein, was present in the DAT implants in the first 2 weeks and showed enhanced expression of CD68, Arginase-1, and CD163, along with reduced expression of iNOS. MicroCT angiography revealed a similar perfused vessel network in the seeded and unseeded groups at 4- and 8-weeks post-implantation. Overall, seeding with syngeneic ASCs modulated the host macrophage response to the DAT bioscaffolds at early timepoints, but did not impact long-term regenerative outcomes, potentially due to the rapid clearance of the donor cell population in this model. STATEMENT OF SIGNIFICANCE: Decellularized adipose tissue (DAT) is a promising biomaterial for treating soft tissue defects. Seeding with adipose-derived stromal cells (ASCs) can augment fat regeneration within DAT in pre-clinical models, but our understanding of how ASCs contribute to tissue regeneration in vivo remains limited. Furthermore, ASC clearance from implanted biomaterials is well described, but poorly understood. Here, ASC-seeded DAT was implanted subcutaneously in immunocompetent mice to assess how ASCs altered the host macrophage response, functional vascular regeneration, and long-term integration with the host tissues. Additionally, ASC phenotype and persistence were assessed to determine how these cells might be cleared from the implants. Such understanding is critical to design biomaterials that can better harness the therapeutic benefits of ASCs.

1 April 2019 in Cell Metabolism
Verified
Journal Article
Closed access
TCTyler T. Cooper
Tyler T. Cooper
DHDavid Hess
David Hess
SVSubodh Verma
Subodh Verma

1 April 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
TCTyler T. Cooper
Tyler T. Cooper
DDDylan Z. Dieters-Castator
Dylan Z. Dieters-Castator
JLJiahui Liu
Jiahui Liu
GSGabrielle Siegers
Gabrielle Siegers
DPDesmond Pink
Desmond Pink
LPLynne-Marie Postovit
Lynne-Marie Postovit
Purpose: The five-year prognosis for patients with late-stage high-grade serous carcinoma (HGSC) remains dismal, underscoring the critical need for identifying early-stage biomarkers. This study explores the potential of extracellular vesicles (EVs) circulating in blood, which are believed to harbor proteomic cargo reflective of the HGSC microenvironment, as a source for biomarker discovery. Experimental Design: We conducted a comprehensive proteomic profiling of EVs isolated from blood plasma, ascites, and cell lines of patients, employing both data-dependent (DDA) and data-independent acquisition (DIA) methods to construct a spectral library tailored for targeted proteomics. Our investigation aimed at uncovering novel biomarkers for the early detection of HGSC by comparing the proteomic signatures of EVs from women with HGSC to those with benign gynecological conditions. The initial cohort, comprising 9-10 donors, utilized DDA proteomics for spectral library development. The subsequent cohort, involving 30 HGSC patients and 30 control subjects, employed DIA proteomics for a similar purpose. Support vector machine (SVM) classification was applied in both cohorts to identify combinatorial biomarkers with high specificity and sensitivity (ROC-AUC > 0.90). Results: Notably, MUC1 emerged as a significant biomarker in both cohorts when used in combination with additional biomarkers. Validation through an ELISA assay on a subset of benign (n=18), Stage I (n=9), and stage II (n=9) plasma samples corroborated the diagnostic utility of MUC1 in the early-stage detection of HGSC. Conclusions: This study highlights the value of EV-based proteomic analysis in the discovery of combinatorial biomarkers for early ovarian cancer detection.